Kavaljer
Kavaljer Investmentbolagsfond
Global Mega-cap
May 2026 → Sep 2026
Our archive holds 3 letters from this strategy, behind 8 investment theses and positions in 22 companies. Every quote below is copied verbatim from the letter it came from.
3 letters in a year · follow all of Kavaljer for every strategy.
Performance
as of Sep 30, 2026 · net of fees · SEK
- YTD+1.0%index +10.4%
- 1Y+5.0%index +18.0%
- Inception · total+154%index +142%
Index: OMXSPI-GI
| YTD | 1Y | Since inceptiontotal | |
|---|---|---|---|
| Kavaljer Investmentbolagsfond | +1.0% | +5.0% | +154% |
| OMXSPI-GI | +10.4% | +18.0% | +142% |
Disclaimer
These figures are copied from the manager’s latest letter, as of Sep 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.
Read full disclosures →What it bought and sold
- TrimmedBeijer AlmaSep 2026
During the month the fund reduced its holdings in Beijer Alma and Vitec Software.
- TrimmedVitec SoftwareSep 2026
During the month the fund reduced its holdings in Beijer Alma and Vitec Software.
- New positionFlat CapitalSep 2026
Flat Capital is a new holding.
The fund increased its holding in Danaher on the day of the report, as the share price decline was judged to be excessive.
During the month, the fund reduced its holdings in Bure Equity, Idun Industrier and Industrivärden, and fully divested its holding in VEF.
During the month, the fund reduced its holdings in Bure Equity, Idun Industrier and Industrivärden, and fully divested its holding in VEF.
- TrimmedIndustrivärdenJul 2026
During the month, the fund reduced its holdings in Bure Equity, Idun Industrier and Industrivärden, and fully divested its holding in VEF.
The fund added to Alphabet, Danaher, Lifco and Siemens AG.
The fund added to Alphabet, Danaher, Lifco and Siemens AG.
- AddedLifcoJul 2026
The fund added to Alphabet, Danaher, Lifco and Siemens AG.
During the month, the fund reduced its holdings in Bure Equity, Idun Industrier and Industrivärden, and fully divested its holding in VEF.
- TrimmedLundbergsMay 2026
During the month, the fund reduced its holdings in Berkshire Hathaway and Lundbergs,
New positions are Alphabet and Thermo Fisher.
New positions are Alphabet and Thermo Fisher.
During the month, the fund reduced its holdings in Berkshire Hathaway and Lundbergs, and fully divested its positions in Dometic, Green Landscaping, VNV Global, and Spiltan Invest.
During the month, the fund reduced its holdings in Berkshire Hathaway and Lundbergs,
During the month, the fund reduced its holdings in Berkshire Hathaway and Lundbergs, and fully divested its positions in Dometic, Green Landscaping, VNV Global, and Spiltan Invest.
- ExitedSpiltan InvestMay 2026
During the month, the fund reduced its holdings in Berkshire Hathaway and Lundbergs, and fully divested its positions in Dometic, Green Landscaping, VNV Global, and Spiltan Invest.
During the month, the fund reduced its holdings in Berkshire Hathaway and Lundbergs, and fully divested its positions in Dometic, Green Landscaping, VNV Global, and Spiltan Invest.
Also held
- Berkshire Hathaway
- Markel
- Latour
- BB Biotech
- Alphabet
- Svolder
- Lifco
- Microsoft
- LVMH
- Industrivärden
- Investor
- Ratos
- HBM Healthcare Investments
- Prosus
- Linc
- Danaher
- Bure Equity
- Thermo Fisher Scientific
- Siemens AG
- Fairfax Financial Holdings
- Beijer Alma
- Securitas
- Mycronic
- Assa Abloy
Its investment theses
- Thermo Fisher ScientificSep 2026Thermo Fisher Scientific is positioned to benefit from recovering volumes, AI-driven lab investment, and operating leverage across its broad life-science platform.
- BB BiotechSep 2026BB Biotech owns a concentrated portfolio of validated biotech companies and trades at a NAV discount despite improved sector conditions.
- HBM Healthcare InvestmentsSep 2026HBM Healthcare has significant unlisted biotech exposure and trades at a NAV discount despite a more favorable funding environment.
- LincSep 2026Linc invests in Nordic life science companies and is seen as attractive due to its NAV discount, buybacks, and strong balance sheet.
- LatourSep 2026Latour is supported by improving markets and Nord-Lock’s strong niche positions, high returns on capital, and bolt-on acquisition potential.
- SvolderSep 2026Svolder focuses on quality small-cap companies with strong market positions, and its long-term track record supports the investment case.
- DanaherMay 2026Danaher is a recurring-revenue life science and diagnostics compounder with improving bioprocessing demand, AI tailwinds, and a discounted valuation.
- Vitec Software GroupMay 2026Vitec Software Group is returning to organic growth and margin expansion, with AI efficiencies, manageable leverage, and a low valuation supporting upside.